Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ

Human Pathology

Volumn 31, Issue 2, 2000, Pages 201-207

  Visscher, Daniel ^a,b   Jimenez, Rafael E ^a   Grayson III, McComma ^a   Mendelin, Joel ^a   Wallis, Tracie ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Chromosome aneuploidy; Ductal carcinoma in situ; Fluorescent in situ hybridization; Genetic instability

Indexed keywords

ANEUPLOIDY; BREAST CARCINOGENESIS; CANCER GRADING; CARCINOMA IN SITU; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA;

EID: 0033967617     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(00)80220-8     Document Type: Conference Paper

References (28)

1. Cady B Stone MD Schuler JG The new era in breast cancer: Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening Arch Surg 131 1996 301 308
2. Lennington WJ Jensen RA Dalton LW Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions Cancer 73 1994 118 124
3. Lagios MD Duct carcinoma in situ: Pathology and treatment Surg Clin North Am 70 1990 853 871
4. Lagios MD Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: Defining cohorts for chemoprevention trials Journal of Cellular Biochemistry Supplement 25 1996 108 111
5. Mack L Kerkvliet N Doig G Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67 [see comments] Hum Pathol 28 1997 974 979
6. Moreno A Lloveras B Figueras A Ductal carcinoma in situ of the breast: Correlation between histologic classifications and biologic markers Mod Pathol 10 1997 1088 1092
7. Schnitt SJ Connolly JL Classification of ductal carcinoma in situ: Striving for clinical relevance in the era of breast conserving therapy [editorial; comment] Hum Pathol 28 1997 877 880
8. Scott MA Lagios MD Axelsson K Ductal carcinoma in situ of the breast: Reproducibility of histological subtype analysis [see comments] Hum Pathol 28 1997 967 973
9. Tavassoli FA Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia Mod Pathol 11 1998 140 154
10. Delaney G Ung O Bilous M Ductal carcinoma in situ. Part I: Definition and diagnosis Aust N Z J Surg 67 1997 81 93
11. Davidoff AM Kerns BJ Iglehart JD Maintenance of p53 alterations throughout breast cancer progression Cancer Res 51 1991 2605 2610
12. Aasmundstad TA Haugen OA DNA ploidy in intraductal breast carcinomas Eur J Cancer 26 1990 956 959
13. Sneige N Sahin A Dinh M Interphase cytogenetics in mammographically detected breast lesions Hum Pathol 27 1996 330 335
14. Radford DM Phillips NJ Fair KL Allelic loss and the progression of breast cancer [published erratum appears in Cancer Res 1996 Feb 15;56(4):935] Cancer Res 55 1995 5180 5183
15. Nielsen KV Andersen JA Blichert-Toft M Chromosome changes of in situ carcinomas in the female breast Eur J Surg Oncol 13 1987 225 229
16. Nielsen KV Blichert-Toft M Andersen J Chromosome analysis of in situ breast cancer Acta Oncol 28 1989 919 922
17. Fujii H Szumel R Marsh C Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast Cancer Res 56 1996 5260 5265
18. Geleick D Muller H Matter A Cytogenetics of breast cancer Cancer Genet Cytogenet 46 1990 217 229
19. Dutrillaux B Gerbault-Seureau M Remvikos Y Breast cancer genetic evolution: I. Data from cytogenetics and DNA content Breast Cancer Res Treat 19 1991 245 255
20. Shackney SE Singh SG Yakulis R Aneuploidy in breast cancer: A fluorescence in situ hybridization study Cytometry 22 1995 282 291
21. (in press) Mendelin J Grayson M Wallis T Analysis of chromosome aneuploidy in breast carcinoma progression using fluorescence in situ hybridization Lab Invest 1999
22. Holland R Peterse JL Millis RR Ductal carcinoma in situ: A proposal for a new classification Semin Diagn Pathol 11 1994 167 180
23. Harrison M Magee HM O'Loughlin J Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast J Pathol 175 1995 303 309
24. Visscher DW Wallis T Ritchie CA Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: Comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis Cytometry 21 1995 95 100
25. Visscher DW Wallis TL Crissman JD Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics Cancer 77 1996 315 320
26. Bins M Takens F A method to estimate the DNA content of whole nuclei from measurements made on thin tissue sections Cytometry 6 1985 234 237
27. Kuukasjarvi T Tanner M Pennanen S Genetic changes in intraductal breast cancer detected by comparative genomic hybridization Am J Pathol 150 1997 1465 1471
28. Noguchi S Aihara T Koyama H Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis Cancer 74 1994 872 877